These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33600254)

  • 1. NEXT Harm Reduction: An Online, Mail-Based Naloxone Distribution and Harm-Reduction Program.
    Yang C; Favaro J; Meacham MC
    Am J Public Health; 2021 Apr; 111(4):667-671. PubMed ID: 33600254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding Mail-Based Distribution of Drug-Related Harm Reduction Supplies Amid COVID-19 and Beyond.
    Barnett BS; Wakeman SE; Davis CS; Favaro J; Rich JD
    Am J Public Health; 2021 Jun; 111(6):1013-1017. PubMed ID: 33950718
    [No Abstract]   [Full Text] [Related]  

  • 3. Accessing Take-Home Naloxone in British Columbia and the role of community pharmacies: Results from the analysis of administrative data.
    Moustaqim-Barrette A; Papamihali K; Mamdani Z; Williams S; Buxton JA
    PLoS One; 2020; 15(9):e0238618. PubMed ID: 32915834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid overdose prevention and naloxone rescue kits: what we know and what we don't know.
    Kerensky T; Walley AY
    Addict Sci Clin Pract; 2017 Jan; 12(1):4. PubMed ID: 28061909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacists are missing an opportunity to save lives and advance the profession by embracing opioid harm reduction.
    Hill LG; Evoy KE; Reveles KR
    J Am Pharm Assoc (2003); 2019; 59(6):779-782. PubMed ID: 31402146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland.
    O'Halloran C; Cullen K; Njoroge J; Jessop L; Smith J; Hope V; Ncube F
    Int J Drug Policy; 2017 Aug; 46():34-40. PubMed ID: 28586701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Overdose Education and Naloxone Distribution Program of the Baltimore Student Harm Reduction Coalition.
    Lewis DA; Park JN; Vail L; Sine M; Welsh C; Sherman SG
    Am J Public Health; 2016 Jul; 106(7):1243-6. PubMed ID: 27077351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxone Counseling for Harm Reduction and Patient Engagement.
    Han JK; Hill LG; Koenig ME; Das N
    Fam Med; 2017 Oct; 49(9):730-733. PubMed ID: 29045991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The implementation and role of a staff naloxone program for non-profit community-based sites in British Columbia: A descriptive study.
    Williams S; King T; Papamihali K; Buxton JA
    PLoS One; 2021; 16(5):e0251112. PubMed ID: 33983996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid Overdose Prevention Programs Providing Naloxone to Laypersons - United States, 2014.
    Wheeler E; Jones TS; Gilbert MK; Davidson PJ;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):631-5. PubMed ID: 26086633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing peer recovery services for overdose prevention in Rhode Island: An examination of two outreach-based approaches.
    Waye KM; Goyer J; Dettor D; Mahoney L; Samuels EA; Yedinak JL; Marshall BDL
    Addict Behav; 2019 Feb; 89():85-91. PubMed ID: 30278306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants.
    Barocas JA; Baker L; Hull SJ; Stokes S; Westergaard RP
    Drug Alcohol Depend; 2015 Sep; 154():283-6. PubMed ID: 26143300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose.
    Doe-Simkins M; Walley AY; Epstein A; Moyer P
    Am J Public Health; 2009 May; 99(5):788-91. PubMed ID: 19363214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015.
    Stopka TJ; Donahue A; Hutcheson M; Green TC
    J Am Pharm Assoc (2003); 2017; 57(2S):S34-S44. PubMed ID: 28189540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overdose Education and Naloxone Distribution in the San Francisco County Jail.
    Wenger LD; Showalter D; Lambdin B; Leiva D; Wheeler E; Davidson PJ; Coffin PO; Binswanger IA; Kral AH
    J Correct Health Care; 2019 Oct; 25(4):394-404. PubMed ID: 31672075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey of Southern Wisconsin Needle Exchange Clients Regarding Opioid Overdose and Naloxone Use.
    Baltes A; Devo B; Kaiser M; Birstler J; Brown RT
    WMJ; 2019 Jul; 118(2):84-87. PubMed ID: 31532934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing Fear of Negative Consequences of Overdose Response: A Qualitative Study of the Perceptions of Service Industry Workers Who Encounter an Opioid Overdose in an Urban Commercial District in Atlanta, Georgia.
    Febres-Cordero S; Thompson LM; Chalfant OS; Sherman ADF; Winiker AK; Kelly UA; Smith KM
    Workplace Health Saf; 2024 Jun; 72(6):244-252. PubMed ID: 38243156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the accessibility of harm reduction services in the United States: Measuring the impact of an automated harm reduction dispensing machine.
    Arendt D
    J Am Pharm Assoc (2003); 2023; 63(1):309-316. PubMed ID: 36549931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives.
    Lintzeris N; Monds LA; Bravo M; Read P; Harrod ME; Gilliver R; Wood W; Nielsen S; Dietze PM; Lenton S; Shanahan M; Jauncey M; Jefferies M; Hazelwood S; Dunlop AJ; Greenaway M; Haber P; Ezard N; Malcom A
    Drug Alcohol Rev; 2020 Jan; 39(1):55-65. PubMed ID: 31774221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada.
    Strike C; Watson TM
    Int J Drug Policy; 2019 Sep; 71():178-182. PubMed ID: 30975595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.